Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Aug;84(2):458–467. doi: 10.1172/JCI114187

Mechanisms underlying regional differences in lipolysis in human adipose tissue.

H Wahrenberg 1, F Lönnqvist 1, P Arner 1
PMCID: PMC548904  PMID: 2503539

Abstract

Catecholamine-induced lipolysis was investigated in nonobese females and males. Isolated subcutaneous adipocytes were obtained from the abdominal and gluteal regions. The lipolytic effect of noradrenaline was four to fivefold more marked in abdominal adipocytes than in gluteal fat cells. This regional difference was more apparent in females than in males. No site differences were observed when lipolysis was stimulated with agents acting at different postreceptor levels. The beta-adrenergic lipolytic sensitivity was 10-20 times greater in abdominal adipocytes from both sexes than in gluteal adipocytes. Abdominal adipocytes from females showed a 40 times lower alpha 2-adrenergic antilipolytic sensitivity than did gluteal adipocytes, but the adenosine receptor sensitivity was similar in both sites. Beta-receptor affinity for agonists displayed no site or sex variation. Abdominal adipocytes showed a twofold increased beta-adrenoceptor density than did gluteal cells from both sexes. The alpha 2-adrenoceptor density was similar in all regions, but in females the affinity of clonidine for these sites was 10-15 times lower in the abdominal fat cells compared with gluteal cells. In conclusion, regional differences in catecholamine-induced lipolysis are regulated at the adrenoceptor level, chiefly because of site variations in beta-adrenoceptor density. Further variations in the affinity properties of alpha 2-adrenergic receptor in females may explain why the regional differences in catecholamine-induced lipolysis are more pronounced in women than in men.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner P., Arner O., Ostman J. The effect of local anaesthetic agents on lipolysis by human adipose tissue. Life Sci. 1973 Jul 16;13(2):161–169. doi: 10.1016/0024-3205(73)90191-4. [DOI] [PubMed] [Google Scholar]
  2. Arner P., Hellmér J., Wennlund A., Ostman J., Engfeldt P. Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate. Eur J Pharmacol. 1988 Jan 27;146(1):45–56. doi: 10.1016/0014-2999(88)90485-2. [DOI] [PubMed] [Google Scholar]
  3. Arner P., Ostman J. Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue. J Lipid Res. 1978 Jul;19(5):613–618. [PubMed] [Google Scholar]
  4. Björkhem I., Arner P., Thore A., Ostman J. Sensitive kinetic bioluminescent assay of glycerol release from human fat cells. J Lipid Res. 1981 Sep;22(7):1142–1147. [PubMed] [Google Scholar]
  5. Burns T. W., Langley P. E. Lipolysis by human adipose tissue: the role of cyclic 3',5'-adenosine monophosphate and adrenergic receptor sites. J Lab Clin Med. 1970 Jun;75(6):983–997. [PubMed] [Google Scholar]
  6. Evans D. J., Hoffmann R. G., Kalkhoff R. K., Kissebah A. H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983 Aug;57(2):304–310. doi: 10.1210/jcem-57-2-304. [DOI] [PubMed] [Google Scholar]
  7. Fain J. N., Garcĩa-Sáinz J. A. Adrenergic regulation of adipocyte metabolism. J Lipid Res. 1983 Aug;24(8):945–966. [PubMed] [Google Scholar]
  8. Fredholm B. B., Lindgren E. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. Acta Pharmacol Toxicol (Copenh) 1984 Jan;54(1):64–71. doi: 10.1111/j.1600-0773.1984.tb01896.x. [DOI] [PubMed] [Google Scholar]
  9. Gilman A. G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649. doi: 10.1146/annurev.bi.56.070187.003151. [DOI] [PubMed] [Google Scholar]
  10. Gilman A. G. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J Clin Invest. 1984 Jan;73(1):1–4. doi: 10.1172/JCI111179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kather H., Bieger W., Michel G., Aktories K., Jakobs K. H. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest. 1985 Oct;76(4):1559–1565. doi: 10.1172/JCI112137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kather H., Zöllig K., Simon B., Schlierf G. Human fat cell adenylate cyclase: regional differences in adrenaline responsiveness. Eur J Clin Invest. 1977 Dec;7(6):595–597. doi: 10.1111/j.1365-2362.1977.tb01657.x. [DOI] [PubMed] [Google Scholar]
  13. Krotkiewski M., Björntorp P., Sjöström L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983 Sep;72(3):1150–1162. doi: 10.1172/JCI111040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lacasa D., Agli B., Giudicelli Y. "Spare" beta-adrenergic receptors of rat white adipocyte membranes. Biochem Int. 1984 Aug;9(2):187–195. [PubMed] [Google Scholar]
  15. Lafontan M., Dang-Tran L., Berlan M. Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits. Eur J Clin Invest. 1979 Aug;9(4):261–266. doi: 10.1111/j.1365-2362.1979.tb00883.x. [DOI] [PubMed] [Google Scholar]
  16. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1257–1261. doi: 10.1136/bmj.289.6454.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leibel R. L., Hirsch J. Site- and sex-related differences in adrenoreceptor status of human adipose tissue. J Clin Endocrinol Metab. 1987 Jun;64(6):1205–1210. doi: 10.1210/jcem-64-6-1205. [DOI] [PubMed] [Google Scholar]
  18. Lönnqvist F., Wennlund A., Arner P. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells. Int J Obes. 1989;13(2):137–146. [PubMed] [Google Scholar]
  19. Marcus C., Ehrén H., Bolme P., Arner P. Regulation of lipolysis during the neonatal period. Importance of thyrotropin. J Clin Invest. 1988 Nov;82(5):1793–1797. doi: 10.1172/JCI113793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marcus C., Karpe B., Bolme P., Sonnenfeld T., Arner P. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. J Clin Invest. 1987 Jun;79(6):1812–1818. doi: 10.1172/JCI113022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mauriege P., Galitzky J., Berlan M., Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest. 1987 Apr;17(2):156–165. doi: 10.1111/j.1365-2362.1987.tb02395.x. [DOI] [PubMed] [Google Scholar]
  22. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  23. Ostman J., Arner P., Engfeldt P., Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism. 1979 Dec;28(12):1198–1205. doi: 10.1016/0026-0495(79)90131-8. [DOI] [PubMed] [Google Scholar]
  24. Ostman J., Arner P., Kimura H., Wahrenberg H., Engfeldt P. Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes. Eur J Clin Invest. 1984 Oct;14(5):383–391. doi: 10.1111/j.1365-2362.1984.tb01199.x. [DOI] [PubMed] [Google Scholar]
  25. Ostman J., Efendić S. Catecholamines and metabolism of human adipose tissue. II. Effect of isoprophylnoradrenaline and adrenergic blocking agents on lipolysis in human omental adipose tissue in vitro. Acta Med Scand. 1970 Jun;187(6):471–476. [PubMed] [Google Scholar]
  26. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  27. Seamon K. B., Padgett W., Daly J. W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3363–3367. doi: 10.1073/pnas.78.6.3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith U., Hammersten J., Björntorp P., Kral J. G. Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest. 1979 Oct;9(5):327–332. doi: 10.1111/j.1365-2362.1979.tb00892.x. [DOI] [PubMed] [Google Scholar]
  29. Stoneham S., Kiviluoto T., Keso L., Ohisalo J. J. Adenosine and the regional differences in adipose tissue metabolism in women. Acta Endocrinol (Copenh) 1988 Jul;118(3):327–331. doi: 10.1530/acta.0.1180327. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES